ClinicalTrials.Veeva

Menu

The Effects of Sedatives on Tobacco Use Disorder (SED-TUD)

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status and phase

Completed
Phase 2
Phase 1

Conditions

Tobacco Use Disorder

Treatments

Drug: placebo intravenous infusion
Drug: ketamine intravenous infusion
Drug: midazolam intravenous infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT03813121
IRB000229077

Details and patient eligibility

About

This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.

Enrollment

10 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • smoke at least 5 cigarettes per day
  • smoked at least 2 years
  • negative urine drug screen for psychoactive drugs and negative breath alcohol concentration
  • live in Little Rock AR or surrounding area

Exclusion criteria

  • unstable or stable medical condition that would interact with study medication or participation
  • serious head trauma or neurological disorder
  • hypertension, abnormal ECG or metabolic blood results
  • meet criteria for psychosis, schizophrenia, major depressive disorder, or bipolar disorder
  • use of psychoactive drugs or medications
  • BMI > 40
  • among women, pregnancy or breastfeeding

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

10 participants in 3 patient groups, including a placebo group

midazolam intravenous infusion
Experimental group
Description:
single midazolam infusion (0.02 mg/kg over 20 minutes)
Treatment:
Drug: midazolam intravenous infusion
placebo intravenous infusion
Placebo Comparator group
Description:
single placebo infusion (saline over 20 minutes)
Treatment:
Drug: placebo intravenous infusion
ketamine intravenous infusion
Experimental group
Description:
single ketamine infusion (0.5 mg/kg over 20 minutes)
Treatment:
Drug: ketamine intravenous infusion

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems